GeneFerm Biotechnology Dividend
Dividend criteriumcontroles 1/6
GeneFerm Biotechnology is a dividend paying company with a current yield of 4.15%.
Belangrijke informatie
4.1%
Dividendrendement
n/a
Terugkoop Rendement
| Totaal aandeelhoudersrendement | n/a |
| Toekomstig dividendrendement | n/a |
| Dividendgroei | 13.8% |
| Volgende betaaldatum dividend | n/a |
| Ex-dividenddatum | n/a |
| Dividend per aandeel | NT$2.000 |
| Uitbetalingsratio | 251% |
Stabiliteit en groei van betalingen
Dividenden ophalen
Stabiel dividend: 1796 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Groeiend dividend: 1796 has only been paying a dividend for 8 years, and since then payments have fallen.
Dividendrendement versus markt
| GeneFerm Biotechnology Dividendrendement versus markt |
|---|
| Segment | Dividendrendement |
|---|---|
| Bedrijf (1796) | 4.1% |
| Markt onderkant 25% (TW) | 1.7% |
| Markt Top 25% (TW) | 4.4% |
| Gemiddelde industrie (Personal Products) | 4.6% |
| Analist prognose (1796) (tot 3 jaar) | n/a |
Opmerkelijk dividend: 1796's dividend (4.15%) is higher than the bottom 25% of dividend payers in the TW market (1.71%).
Hoog dividend: 1796's dividend (4.15%) is low compared to the top 25% of dividend payers in the TW market (4.42%).
Winstuitkering aan aandeelhouders
Verdiendekking: With its high payout ratio (251.3%), 1796's dividend payments are not well covered by earnings.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: With its high cash payout ratio (110.6%), 1796's dividend payments are not well covered by cash flows.